Procept BioRobotics gets FDA nod to study surgical robot for treating prostate cancer
Robotics Business Review
OCTOBER 9, 2024
The robotic technology used for the Aquablation procedure. Source: Procept BioRobotics Procept BioRobotics Corp. based company also recently received Breakthrough Device Designation to investigate the use of Aquablation therapy for prostate cancer. last week announced that the U.S. Register now.
Let's personalize your content